1. Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial. (July 2020) Authors: Eggermont, Alexander M.M.; Rutkowski, Piotr; Dutriaux, Caroline; Hofman-Wellenhof, Rainer; Dziewulski, Peter; Marples, Maria; Grange, Floren; Lok, Catherine; Pennachioli, Elisabetta; Robert, Caroline; van Akkooi, Alexander C.J.; Bastholt, Lars; Minisini, Alessandro; Marshall, Ernest; Salès, Franç... Journal: European journal of cancer Issue: Volume 133(2020) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Primary systemic therapy in patients with breast cancer: rationale of use and magnitude of evidence. Issue 1 (1st September 2004) Authors: Puglisi, Fabio; Minisini, Alessandro; Piga, Andrea Journal: Therapy Issue: Volume 1:Issue 1(2004) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. Issue 1 (15th November 2019) Authors: Massi, Daniela; Rulli, Eliana; Cossa, Mara; Valeri, Barbara; Rodolfo, Monica; Merelli, Barbara; De Logu, Francesco; Nassini, Romina; Del Vecchio, Michele; Di Guardo, Lorenza; De Penni, Roberta; Guida, Michele; Sileni, Vanna Chiarion; Di Giacomo, Anna Maria; Tucci, Marco; Occelli, Marcella; Portel... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗